|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meng W, Ye Z, Cui R, Perry J,
Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H,
et al: MicroRNA-31 predicts the presence of lymph node metastases
and survival in patients with lung adenocarcinoma. Clin Cancer Res.
19:5423–5433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li CY, Liang GY, Yao WZ, Sui J, Shen X,
Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, et al: Identification
and functional characterization of microRNAs reveal a potential
role in gastric cancer progression. Clin Transl Oncol. 19:162–172.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Babu KR and Muckenthaler MU: miR-20a
regulates expression of the iron exporter ferroportin in lung
cancer. J Mol Med (Berl). 94:347–359. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu W, Dang S, Feng Q, Liang J, Wang Y and
Fan N: MicroRNA-542-3p inhibits the growth of hepatocellular
carcinoma cells by targeting FZD7/Wnt signaling pathway. Biochem
Biophys Res Commun. 482:100–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren C, Chen H, Han C, Fu D, Wang D and
Shen M: High expression of miR-16 and miR-451 predicating better
prognosis in patients with gastric cancer. J Cancer Res Clin Oncol.
142:2489–2496. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Li M, Wang Z, Han S, Tang X, Ge Y,
Zhou L, Zhou C, Yuan Q and Yang M: Silencing of long noncoding RNA
MALAT1 by miR-101 and miR-217 inhibits proliferation, migration,
and invasion of esophageal squamous cell carcinoma cells. J Biol
Chem. 290:3925–3935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Borel C and Antonarakis SE: Functional
genetic variation of human miRNAs and phenotypic consequences. Mamm
Genome. 19:503–509. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Becker-Santos DD, Thu KL, English JC,
Pikor LA, Martinez VD, Zhang M, Vucic EA, Luk MT, Carraro A,
Korbelik J, et al: Developmental transcription factor NFIB is a
putative target of oncofetal miRNAs and is associated with tumour
aggressiveness in lung adenocarcinoma. J Pathol. 240:161–172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mou X and Liu S: MiR-485 inhibits
metastasis and EMT of lung adenocarcinoma by targeting Flot2.
Biochem Biophys Res Commun. 477:521–526. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie K, Wang C, Qin N, Yang J, Zhu M, Dai
J, Jin G, Shen H, Ma H and Hu Z: Genetic variants in regulatory
regions of microRNAs are associated with lung cancer risk.
Oncotarget. 7:47966–47974. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sui J, Li YH, Zhang YQ, Li CY, Shen X, Yao
WZ, Peng H, Hong WW, Yin LH, Pu YP, et al: Integrated analysis of
long non-coding RNA-associated ceRNA network reveals potential
lncRNA biomarkers in human lung adenocarcinoma. Int J Oncol.
49:2023–2036. 2016.PubMed/NCBI
|
|
18
|
Li CY, Liang GY, Yao WZ, Sui J, Shen X,
Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, et al: Integrated
analysis of long non-coding RNA competing interactions reveals the
potential role in progression of human gastric cancer. Int J Oncol.
48:1965–1976. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie J and Liu C: Adjusted Kaplan-Meier
estimator and log-rank test with inverse probability of treatment
weighting for survival data. Stat Med. 24:3089–3110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Branders S and Dupont P: A balanced hazard
ratio for risk group evaluation from survival data. Stat Med.
34:2528–2543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sana J, Faltejskova P, Svoboda M and Slaby
O: Novel classes of non-coding RNAs and cancer. J Transl Med.
10:1032012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang DY, Wu YN, Huang JQ, Wang W, Xu M,
Jia JP, Han G, Mao BB and Bi WZ: Hippo/YAP signaling pathway is
involved in osteosarcoma chemoresistance. Chin J Cancer. 35:472016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mo X, Cao Q, Liang H, Liu J, Li H and Liu
F: MicroRNA-610 suppresses the proliferation of human glioblastoma
cells by repressing CCND2 and AKT3. Mol Med Rep. 13:1961–1966.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kerr KM: Pulmonary adenocarcinomas:
Classification and reporting. Histopathology. 54:12–27. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoshizawa A, Motoi N, Riely GJ, Sima CS,
Gerald WL, Kris MG, Park BJ, Rusch VW, Travis WD, et al: Impact of
proposed IASLC/ATS/ERS classification of lung adenocarcinoma:
prognostic subgroups and implications for further revision of
staging based on analysis of 514 stage I cases. Mod pathol.
24:653–664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ortea I, Rodríguez-Ariza A, Chicano-Gálvez
E, Vacas Arenas MS and Jurado Gámez B: Discovery of potential
protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage
fluid by SWATH MS data-independent acquisition and targeted data
extraction. J Proteomics. 138:106–114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
De Luca A, Maiello MR, DAlessio A,
Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT
signalling pathways: Role in cancer pathogenesis and implications
for therapeutic approaches. Expert Opin Ther Targets. 16 Suppl
2:S17–S27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cardarella S and Johnson BE: The impact of
genomic changes on treatment of lung cancer. Am J Respir Crit Care
Med. 188:770–775. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cai Y, Yu X, Hu S and Yu J: A brief review
on the mechanisms of miRNA regulation. Genomics Proteomics
Bioinformatics. 7:147–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi X, Xu Y, Zhang C, Feng L, Sun Z, Han
J, Su F, Zhang Y, Li C and Li X: Subpathway-LNCE: Identify
dysfunctional subpathways competitively regulated by lncRNAs
through integrating lncRNA-mRNA expression profile and pathway
topologies. Oncotarget. 7:69857–69870. 2016.PubMed/NCBI
|
|
32
|
Wu C, Xu B, Zhou Y, Ji M, Zhang D, Jiang J
and Wu C: Correlation between serum IL-1β and miR-144-3p as well as
their prognostic values in LUAD and LUSC patients. Oncotarget.
7:85876–85887. 2016.PubMed/NCBI
|
|
33
|
Ma Y, Zhang P, Yang J, Liu Z, Yang Z and
Qin H: Candidate microRNA biomarkers in human colorectal cancer:
Systematic review profiling studies and experimental validation.
Int J Cancer. 130:2077–2087. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pantaleo MA, Ravegnini G, Astolfi A,
Simeon V, Nannini M, Saponara M, Urbini M, Gatto L, Indio V,
Sammarini G, et al: Integrating miRNA and gene expression profiling
analysis revealed regulatory networks in gastrointestinal stromal
tumors. Epigenomics. 8:1347–1366. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wei Y, He R, Wu Y, Gan B, Wu P, Qiu X, Lan
A, Chen G, Wang Q, Lin X, et al: Comprehensive investigation of
aberrant microRNA profiling in bladder cancer tissues. Tumour Biol.
37:12555–12569. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pichler M, Stiegelbauer V,
Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X,
Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, et al: Genome-wide
microRNA analysis identifies miR-188-3p as novel prognostic marker
and molecular factor involved in colorectal carcinogenesis. Clin
Cancer Res. 23:1323–1333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shao Y, Shen YQ, Li YL, Liang C, Zhang BJ,
Lu SD, He YY, Wang P, Sun QL, Jin YX, et al: Direct repression of
the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small
cell lung cancer. Oncotarget. 7:34011–34021. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xiao P and Liu WL: MiR-142-3p functions as
a potential tumor suppressor directly targeting HMGB1 in
non-small-cell lung carcinoma. Int J Clin Exp Pathol.
8:10800–10807. 2015.PubMed/NCBI
|
|
39
|
Chen Q, Hu H, Jiao D, Yan J, Xu W, Tang X,
Chen J and Wang J: miR-126-3p and miR-451a correlate with
clinicopathological features of lung adenocarcinoma: The underlying
molecular mechanisms. Oncol Rep. 36:909–917. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mathew LK, Lee SS, Skuli N, Rao S, Keith
B, Nathanson KL, Lal P and Simon MC: Restricted expression of
miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas
enhances HIF2α activity. Cancer Discov. 4:53–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rodríguez-González FG, Sieuwerts AM, Smid
M, Look MP, Meijer-van Gelder ME, de Weerd V, Sleijfer S, Martens
JW and Foekens JA: MicroRNA-30c expression level is an independent
predictor of clinical benefit of endocrine therapy in advanced
estrogen receptor positive breast cancer. Breast Cancer Res Treat.
127:43–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shin K, Kim KH, Yoon MS, Suh DS, Lee JY,
Kim A and Eo W: Expression of interactive genes associated with
apoptosis and their prognostic value for ovarian serous
adenocarcinoma. Adv Clin Exp Med. 25:513–521. 2016. View Article : Google Scholar : PubMed/NCBI
|
